Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T-Y Kim

Showing results (151-160 of 216) with videos related to

Pageof 22
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 23, 2016
Phase I study of PF-03446962, a fully human monoclonal antibody against activin receptor-like kinase-1, in patients with hepatocellular carcinomaM Simonelli, P Zucali, A Santoro, et al.
Virology|February 10, 1998
Induction of V3-specific cytotoxic T lymphocyte responses by HIV gag particles carrying multiple immunodominant V3 epitopes of gp120L Luo, Y Li, J S Chang, et al.
Lupus|August 2, 2001
FcgammaRIIa/IIIa polymorphism and its association with clinical manifestations in Korean lupus patientsH R Yun, H K Koh, S S Kim, et al.
Oncogene|July 22, 2014
PHF2 histone demethylase acts as a tumor suppressor in association with p53 in cancerK-H Lee, J-W Park, H-S Sung, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 27, 2023
Nivolumab in sorafenib-naive and sorafenib-experienced patients with advanced hepatocellular carcinoma: 5-year follow-up from CheckMate 040A B El-Khoueiry, J Trojan, T Meyer, et al.
British Journal of Cancer|January 8, 2009
Phase II study and biomarker analysis of cetuximab combined with modified FOLFOX6 in advanced gastric cancerS-W Han, D-Y Oh, S-A Im, et al.
British Journal of Cancer|November 13, 2008
Cancer patients' awareness of clinical trials, perceptions on the benefit and willingness to participate: Korean perspectivesJ W Kim, S-J Kim, Y-H Chung, et al.
British Journal of Cancer|March 5, 2009
Biomarker analysis in stage III-IV (M0) gastric cancer patients who received curative surgery followed by adjuvant 5-fluorouracil and cisplatin chemotherapy: epidermal growth factor receptor (EGFR) associated with favourable survivalJ-S Kim, M-A Kim, T M Kim, et al.
British Journal of Cancer|February 20, 2008
High tumour islet macrophage infiltration correlates with improved patient survival but not with EGFR mutations, gene copy number or protein expression in resected non-small cell lung cancerD-W Kim, H S Min, K-H Lee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 12, 2007
A phase II trial of S-1 and cisplatin in patients with metastatic or relapsed biliary tract cancerY J Kim, S-A Im, H G Kim, et al.
Pageof 22

Showing results (151-160 of 216) with videos related to

Sort By:
Pageof 22
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 23, 2016
Phase I study of PF-03446962, a fully human monoclonal antibody against activin receptor-like kinase-1, in patients with hepatocellular carcinomaM Simonelli, P Zucali, A Santoro, et al.
Virology|February 10, 1998
Induction of V3-specific cytotoxic T lymphocyte responses by HIV gag particles carrying multiple immunodominant V3 epitopes of gp120L Luo, Y Li, J S Chang, et al.
Lupus|August 2, 2001
FcgammaRIIa/IIIa polymorphism and its association with clinical manifestations in Korean lupus patientsH R Yun, H K Koh, S S Kim, et al.
Oncogene|July 22, 2014
PHF2 histone demethylase acts as a tumor suppressor in association with p53 in cancerK-H Lee, J-W Park, H-S Sung, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 27, 2023
Nivolumab in sorafenib-naive and sorafenib-experienced patients with advanced hepatocellular carcinoma: 5-year follow-up from CheckMate 040A B El-Khoueiry, J Trojan, T Meyer, et al.
British Journal of Cancer|January 8, 2009
Phase II study and biomarker analysis of cetuximab combined with modified FOLFOX6 in advanced gastric cancerS-W Han, D-Y Oh, S-A Im, et al.
British Journal of Cancer|November 13, 2008
Cancer patients' awareness of clinical trials, perceptions on the benefit and willingness to participate: Korean perspectivesJ W Kim, S-J Kim, Y-H Chung, et al.
British Journal of Cancer|March 5, 2009
Biomarker analysis in stage III-IV (M0) gastric cancer patients who received curative surgery followed by adjuvant 5-fluorouracil and cisplatin chemotherapy: epidermal growth factor receptor (EGFR) associated with favourable survivalJ-S Kim, M-A Kim, T M Kim, et al.
British Journal of Cancer|February 20, 2008
High tumour islet macrophage infiltration correlates with improved patient survival but not with EGFR mutations, gene copy number or protein expression in resected non-small cell lung cancerD-W Kim, H S Min, K-H Lee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 12, 2007
A phase II trial of S-1 and cisplatin in patients with metastatic or relapsed biliary tract cancerY J Kim, S-A Im, H G Kim, et al.
Pageof 22